Palisade Bio, Inc.
DE ˙ DB
SecurityDE:7NS0 / Palisade Bio, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership5,373,951 shares
Latest Disclosed Value $ 9,404,414
Goldman Sachs Group Inc ownership in 7NS0 / Palisade Bio, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 5,373,951 shares of Palisade Bio, Inc. (DE:7NS0) valued at $9,404,414 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 557,565 shares of Palisade Bio, Inc.. This represents a change in shares of 863.83% during the quarter.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (7NS0) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:7NS0 / Palisade Bio, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PALISADE BIO CMN 696389402 5,373,951 4,816,386 863.83 9,404 617.86 0.0003
2026-02-10 2025-12-31 13F PALISADE BIO CMN 696389402 557,565 557,565 1,310 0.0002
2017-05-18 2017-03-31 13F/A-1 NEURALSTEM CMN 64127R302 0 -10,440 -100.00 0 -100.00
2017-02-14 2016-12-31 13F NEURALSTEM CMN 64127R302 10,440 -2,110 -16.81 3 -25.00 0.0000
2016-11-14 2016-09-30 13F NEURALSTEM CMN 64127R302 12,550 -2,473 -16.46 4 0.00 0.0000
2016-08-15 2016-06-30 13F NEURALSTEM CMN 64127R302 15,023 1,252 9.09 4 -60.00 0.0000
2016-05-13 2016-03-31 13F NEURALSTEM CMN 64127R302 13,771 -145,301 -91.34 10 -93.90 0.0000
2016-02-16 2015-12-31 13F NEURALSTEM CMN 64127R302 159,072 -181,495 -53.29 164 -60.48 0.0001
2015-11-13 2015-09-30 13F NEURALSTEM CMN 64127R302 340,567 -395,372 -53.72 415 -70.94 0.0001
2015-08-14 2015-06-30 13F NEURALSTEM CMN 64127R302 735,939 725,782 7,145.63 1,428 7,415.79 0.0004
2015-05-15 2015-03-31 13F NEURALSTEM CMN 64127R302 10,157 -8,176 -44.60 19 -62.00 0.0000
2015-02-13 2014-12-31 13F NEURALSTEM CMN 64127R302 18,333 -129,106 -87.57 50 -89.67 0.0000
2014-11-14 2014-09-30 13F NEURALSTEM CMN 64127R302 147,439 -59,442 -28.73 484 -44.56 0.0002
2014-08-14 2014-06-30 13F NEURALSTEM CMN 64127R302 206,881 92,955 81.59 873 83.02 0.0003
2014-05-15 2014-03-31 13F NEURALSTEM CMN 64127R302 113,926 113,926 267.14 477 1,262.86 0.0002
2013-06-14 2012-06-30 13F/A-2 NEURALSTEM CMN 64127R302 0 -31,031 -100.00 0 -100.00
2013-06-14 2012-03-31 13F/A-1 NEURALSTEM CMN 64127R302 31,031 31,031 35 0.0000
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-11-13 2015-09-30 13F NEURALSTEM CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F NEURALSTEM CMN Put 286,200 555 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.